Scientific publications

Role of extended type R2 lymphadenectomy in the surgical treatment of resectable gastric cancer

Dec 1, 1994 | Magazine: Revista Española de Enfermedades Digestivas

Regueira FM, Hernández-Lizoain JL, Torramadé J, Díez-Caballero A, Sierra A, Pardo F, Cienfuegos JA.
Dpto. de Cirugía General, Clínica Universitaria de Navarra, Pamplona.


The extended lymphadenectomy has been proposed as routine procedure in the surgical treatment of gastric cancer, although some controversies have been published. We present a retrospective analysis on the impact of extended lymph node dissection after total gastrectomy, in terms of post-operative course and histopathologic findings, in a group of 30 patients with R2 lymphadenectomy and in 16 patients with R1 lymphadenectomy.

There were no significant differences in duration of operation, amount of blood transfusion and length of hospital stay between the 2 groups. The only significant difference was found in the greater amount of drainage output after R2 lymphadenectomy as compared with R1. There were no mortalities in either group and morbidity rate was similar for both [43% in R1 and 40% in R2) mostly in the form of abdominal infections (18% in R1 and 16% in R2]). A significantly greater number of lymph nodes was identified after R2 gastrectomy. Fifty-three per cent of patients has positive lymph nodes, 12% of them being from the N2 echelon of nodes (including one case of early gastric cancer).

Careful lymph node dissection in gastric cancer surgery allows a more precise staging of the tumor with no increase in postoperative morbidity.

CITATION  Rev Esp Enferm Dig. 1994 Dec;86(6):884-90